A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review
Pain and Therapy · 2025-02 · 14 (1) · 81-101
DOI: 10.1007/s40122-024-00685-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pain and Therapy, online erschienen am 04.12.2024. Verfasst von Giustino Varrassi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Paolo Procacci, 00193, Rome, Italy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
Palmitoylethanolamide (PEA) has been prescribed in neuropathic pain management for over 20 years. This study aims to summarize what has been published on the topic in the last 15 years and determine the appropriateness of the prescribing. It describes the pharmacological aspect of PEA, especially focusing on its pharmacodynamics and pharmacokinetics. Then, it deeply explores why PEA may be useful in the pharmacological management of both neuropathic and mixed pain. Finally, it examines some innovative patent, which aims to address obstacles encountered with conventional PEA formulations, for its pharmacodynamic characteristics. One of them (Equisetum-PEA) seems promising. It partially ameliorates the bioavailability and the targeted distribution. It seems to introduce novel advancements that can potentially enhance the therapeutic effectiveness of PEA in terms of its anti-inflammatory, antioxidant, and analgesic properties. The deep literature analysis aims to examine the potential advantages of PEA, in the context of several pathological conditions that may benefit from this molecule. It focuses on various published data regarding the clinical efficacy of PEA in managing neuropathic and mixed pain. Also, it tries to understand if it can modernize the field of therapy based on PEA, thus offering a better treatment option for individuals with chronic long-term inflammation, oxidative stress, and neuropathic or mixed pain with a neuropathic component. The study examines the possible impact of PEA on personalized medicine strategies and its potential for translation into clinical practice. It analyses the possibilities that PEA has in enhancing patient outcomes in a range of central nervous system and inflammatory conditions. A complete analysis of the therapeutic potentialities of this product was missing. This extensive narrative review makes a valuable contribution to the ongoing comprehension of PEA therapy. It establishes a foundation for further exploration in research and potential uses in clinical settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fondazione Paolo Procacci, 00193, Rome, Italy.
- Department of Anesthesia and Pain Management, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Roma, Rome, Italy.
- Anesthesia and Pain Medicine, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081, Baronissi, Italy.
- Department of Medical Sciences and Public Health, Università di Cagliari, 09042, Monserrato, Italy.
- Department of Medical Sciences and Public Health, Università di Cagliari, 09042, Monserrato, Italy. salvatore.sardo@unica.it.
Zitieren
APA
Varrassi, G., Rekatsina, M., Leoni, M. L. G., Cascella, M., Finco, G., Sardo, S., Corno, C., Tiso, D., Schweiger, V., Fornasari, D. M. M., & Paladini, A. (2025). A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review. Pain and Therapy, 14(1), 81-101. https://doi.org/10.1007/s40122-024-00685-4
Vancouver
Varrassi G, Rekatsina M, Leoni MLG, Cascella M, Finco G, Sardo S, et al. A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review. Pain and Therapy. 2025;14(1):81-101. doi:10.1007/s40122-024-00685-4
BibTeX
@article{Varrassi2025,
author = {Varrassi, Giustino and Rekatsina, Martina and Leoni, Matteo Luigi Giuseppe and Cascella, Marco and Finco, Gabriele and Sardo, Salvatore and Corno, Chiara and Tiso, Domenico and Schweiger, Vittorio and Fornasari, Diego Maria Michele and Paladini, Antonella},
title = {A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review},
journal = {Pain and Therapy},
year = {2025},
volume = {14},
number = {1},
pages = {81--101},
doi = {10.1007/s40122-024-00685-4}
}
EUVIMED